ATE14581T1 - Chemisches verfahren. - Google Patents

Chemisches verfahren.

Info

Publication number
ATE14581T1
ATE14581T1 AT82302664T AT82302664T ATE14581T1 AT E14581 T1 ATE14581 T1 AT E14581T1 AT 82302664 T AT82302664 T AT 82302664T AT 82302664 T AT82302664 T AT 82302664T AT E14581 T1 ATE14581 T1 AT E14581T1
Authority
AT
Austria
Prior art keywords
pyridyl
chemical process
methoxy
methyl
yrimid
Prior art date
Application number
AT82302664T
Other languages
English (en)
Inventor
John Cooper
Wilford Lee Mendelson
George Raymond White
Sidney Harry Levinson
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Application granted granted Critical
Publication of ATE14581T1 publication Critical patent/ATE14581T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Peptides Or Proteins (AREA)
AT82302664T 1981-05-27 1982-05-25 Chemisches verfahren. ATE14581T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8116156 1981-05-27
EP82302664A EP0066442B1 (de) 1981-05-27 1982-05-25 Chemisches Verfahren

Publications (1)

Publication Number Publication Date
ATE14581T1 true ATE14581T1 (de) 1985-08-15

Family

ID=10522080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82302664T ATE14581T1 (de) 1981-05-27 1982-05-25 Chemisches verfahren.

Country Status (11)

Country Link
EP (1) EP0066442B1 (de)
JP (1) JPS57200365A (de)
AT (1) ATE14581T1 (de)
AU (1) AU548256B2 (de)
DE (1) DE3265063D1 (de)
DK (1) DK234982A (de)
ES (1) ES8303399A1 (de)
GR (1) GR75490B (de)
IE (1) IE52967B1 (de)
PT (1) PT74865B (de)
ZA (1) ZA823607B (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1564502A (en) * 1975-07-31 1980-04-10 Smith Kline French Lab Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives

Also Published As

Publication number Publication date
PT74865B (en) 1983-12-07
ES512426A0 (es) 1983-02-01
IE821263L (en) 1982-11-27
JPS57200365A (en) 1982-12-08
GR75490B (de) 1984-07-23
DK234982A (da) 1982-11-28
EP0066442A1 (de) 1982-12-08
DE3265063D1 (en) 1985-09-05
ZA823607B (en) 1983-03-30
ES8303399A1 (es) 1983-02-01
AU8410382A (en) 1982-12-02
AU548256B2 (en) 1985-12-05
EP0066442B1 (de) 1985-07-31
IE52967B1 (en) 1988-04-27
PT74865A (en) 1982-06-01

Similar Documents

Publication Publication Date Title
DK573182A (da) Fremgangsmaade til fremstilling af 2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl)butyl)-1-piperasinyl)pyrimidiner
DK307590A (da) Analogifremgangsmaade til fremstilling af 8-(4-(4-(2,1-benzisothiazol-3-yl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decan-7,9-dion
ES477667A1 (es) Procedimiento para preparar pirimidonas.
DK481879A (da) Fremgangsmaade til fremstilling af 5-(2-imidazolin-2-yl)-aminopyrimidiner eller syreadditionssalte deraf
NO793898L (no) Fremgangsmaate ved drift av et syklisk arbeidende trykkvekseladsorbsjonsanleg.
DK573282A (da) Fremgangsmaade til fremstilling af 2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl)-butyl)-1-piperazinyl)pyridiner
DK160092C (da) Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolin eller ikke-toxiske syreadditionssalte deraf
DK155324C (da) Analogifremgangsmaade til fremstilling af antisekretorisk virksomme heterocyklisk substituerede alfa-(3,4-dichlorphenyl)-methanoler
DK156718C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenyl-2-(pyridyloxy, pyridylamino eller pyridylthio)-ethylaminer eller syreadditionssalte deraf
ATE14581T1 (de) Chemisches verfahren.
FI852423A0 (fi) 1-(bis-(4-fluorofenyl)-metyl)- 4-(3-fenyl-2-propenyl)-hexahydro-1h-1,4-diazepin med kalciumantagonistverkan, dess framstaellning och kompositioner innehaollande densamma.
ES538242A0 (es) Un procedimiento de preparar un derivado de 4,5-dihidro-6-(2-(4-(1h-imidazol-1-il)-fenil)-alquilenil o alquilen-3(2h)-piridazinona.
FI73993B (fi) Foerfarande foer framstaellning av radioaktivt maerkta 8-/4-/4-(2-pyrimidyl)-1-piperazinyl/butyl/-8- azaspiro/4.5/dekan-7,9-dioner.
DE3270566D1 (de) 4-aminomethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
DK140578A (da) Fremgangsmaade til fremstilling af 2-(2!,2!,-trihalogenethyl)-4-halogencyclobutan-1-oner.
ATE14582T1 (de) Chemisches verfahren.
DE3272114D1 (de) 4-(4-phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
DK105679A (da) Fremgangsmaade til fremstilling af 2-(2,2-dimethyl-3-buten-1-yl)-2-oxazoliner
DK337779A (da) Fremgangsmaade til fremstilling af antiinflammatoriske 2-substituerede 1h-phenantro (9,10)-imidazoler
SU653253A1 (ru) Способ получени тиолов
ATE20464T1 (de) 5-oxymethyl-4-acyl-1,3-dihydro-2h-imidazol-2-on .
DD131468A5 (de) Verfahren zur herstellung von 5,6-substituierten,kondensierten 4-(2h)-aminoalkoxy-2,3-pyranonen
DK138853B (da) Analogifremgangsmåde til fremstilling af 1-methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoler eller syreadditionssalte deraf.
DK186781A (da) Fremgangsmaade til fremstilling af 2-substituerede 4,5-dihydro-6-pyridinyl-3(2h)-pyridazioner